-
Analysis Of IDEXX Laboratories' Recent Earnings
Monday, August 21, 2023 - 2:03pm | 1919Read More...With Quiver Quantitative’s recent institutional holdings data, we can see that hedge funds and asset managers have been increasing their holdings in IDEXX Laboratories Inc. (NASDAQ: IDXX). Firms such as Amundi, T. Rowe Price, and State Street have all added to their...
-
Petco Raises $864M In Upsized IPO
Thursday, January 14, 2021 - 3:58am | 326Read More...Petco Health and Wellness Company Inc. announced Wednesday that it issued 48 million shares at $18 per share in its initial public offering. The issue price was higher than the earlier marketed price range of $14 to $17. What Happened: Petco is set to raise $864 million in the IPO and...
-
Elanco Animal Health Announces $245M Stock-For-Stock Acquisition Of Aratana Therapeutics
Friday, April 26, 2019 - 12:33pm | 478Read More...Elanco Animal Health Inc (NYSE: ELAN) announced Friday that it has struck a deal to buy pet therapeutics company Aratana Therapeutics Inc (NASDAQ: PETX). The two companies are partners on the canine drug Galliprant. What Happened The stock-for-stock deal is worth as much as $245...
-
IDEXX Labs Is 'Top Dog'
Thursday, August 24, 2017 - 9:17am | 420Read More...IDEXX Laboratories, Inc. (NASDAQ: IDXX) hosted last week its annual Analyst Day presentation which prompted analysts at Bank of America to upgrade the stock and label it a "top dog." The firm's Derik de Bruin upgrades Idexx's stock rating from Neutral to Buy with an unchanged $175...





